Validation of partin tables for predicting pathological stage of clinically localized prostate cancer

Journal of Urology

Volumn 164, Issue 5, 2000, Pages 1591-1595

  Blute, Michael L ^a   Bergstralh, Erik J ^b   Partin, Alan W ^b   Walsh, Patrick C ^b   Kattan, Michael W ^b   Scardino, Peter T ^b   Montie, James E ^b   Pearson, Jay D ^b   Slezak, Jeffrey M ^b   Zincke, Horst ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Clinical trials; Prostate specific antigen; Prostatic neoplasms; Roc curve

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CANCER GRADING; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PELVIS LYMPHADENECTOMY; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECEIVER OPERATING CHARACTERISTIC; SEMINAL VESICLE; TUMOR BIOPSY;

EID: 0033786710     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67035-8     Document Type: Article

References (25)

1. Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: Influence of tumor deoxyribonucleic acid ploidy
2. Impact of radical prostatectomy in the management of clinically localized disease
3. Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer
4. Correlation of pathologic findings with progression following radical retropubic prostatectomy
5. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer
6. The definition and preoperative prediction of clinically insignificant prostrate cancer
7. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer
8. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update
9. Staging and reporting of prostate cancer - Sampling of the radical prostatectomy specimen
10. Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy
11. Core cancer length in ultrasound-guided systematic sextant biopsies: A preoperative evaluation of prostate cancer volume
12. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis
13. An algorithm for predicting nonorgan confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen level
14. Distinguishing clinically important from unimportant prostate cancers before treatment: Value of systematic biopsies
15. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies
16. Relationship between serum prostate specific antigen, needle biopsy findings, and histopathologic features of prostatic carcinoma in radical prostatectomy tissues
17. Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma
18. The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer
19. Correlation of clinical stage, serum prostatic acid phosphatase, and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate
20. Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Influence of clinical stage and tumor grade
21. Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer
22. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer
23. The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer
24. The role of digital rectal examination, biopsy Gleason sum and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer
25. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening